gaining weight tirzepatide outperformed semaglutide weight-loss drug results in real world patients, study shows I GAINED WEIGHT on Tirzepatide?!

Kossen 2019

But if Lilly investors were concerned about the conflict, it didn't show in the stock market Tuesday

Unlike older medications, tirzepatide activates both GLP-1 and GIP receptors simultaneously

The authors of the secondary analysis also note that research can further focus on why semaglutide produced the effects they observed

Several experimental studies showed that selenium reduces endothelial dysfunction and has a cytoprotective role [96], through SELENOS [97, 98] and SELENOP [99]

Eli Lilly hasn't yet submitted a New Drug Application (NDA) to the FDA, and the earliest realistic approval is late 2027 to 2028